Drugs giant GSK set to sell rare diseases business to step up efficiency drive



DRUGS giant GlaxoSmithKline plans to narrow its research and could sell its rare diseases business as it steps up an efficiency drive under new chief executive, Emma Walmsley.

Source: Daily Express :: Finance Feed http://ift.tt/2va9z7z

Share this

Related Posts

Previous
Next Post »